Dynegy Aktie
WKN DE: A1J5JU / ISIN: US26817R1086
28.07.2025 22:43:45
|
Dyne Therapeutics, Inc. Q2 Loss Increases, Misses Estimates
(RTTNews) - Dyne Therapeutics, Inc. (DYN) announced Loss for its second quarter that increased from last year and missed the Street estimates.
The company's earnings totaled -$110.86 million, or -$0.97 per share. This compares with -$65.10 million, or -$0.70 per share, last year.
Analysts on average had expected the company to earn -$0.93 per share. Analysts' estimates typically exclude special items.
Dyne Therapeutics, Inc. earnings at a glance (GAAP) :
-Earnings: -$110.86 Mln. vs. -$65.10 Mln. last year. -EPS: -$0.97 vs. -$0.70 last year.

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Dynegy Incmehr Nachrichten
Keine Nachrichten verfügbar. |